ACORN
In acutely ill adults (ED / ICU) does the administration of cefipime or piperacillin-tazobactam (pip-taz) result in an increased incidence of AKI or death by day 14?
Continue reading »Special Topic: ID
A compendium of critical appraisals in Intensive Care Medicine research and related specialties
